» Articles » PMID: 35736148

Utility of a Hydrolysate from Overproduced for Hypertension Treatment: Correlation Between Physical Properties and Potent Anti-Hypertensive Activities

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2022 Jun 23
PMID 35736148
Authors
Affiliations
Soon will be listed here.
Abstract

Aquacultured fish are the richest natural source of protein. However, their overproduced biomass is often discarded due to production imbalance, causing considerable losses to the fishery industry. Therefore, it is necessary to utilize surplus fish and add value to overproduced fish. We performed complex enzyme-assisted hydrolysis to determine the correlation between its physical characteristics and anti-hypertensive activity in vitro and in vivo using an SHR model. Protamex-Pepsin assisted hydrolysate from (POH) produced by complex enzyme-assisted hydrolysis contained low-molecular-weight peptides and amino acids with anti-hypertensive activity. POH regulated blood pressure and serum angiotensin II and angiotensin-I-converting enzyme levels, and histological and ultrasound image analysis revealed substantially reduced thickness and diameter of the carotid aorta in the POH-administered SHR group. Therefore, we propose to reduce food loss due to overproduction by utilizing the anti-hypertensive activity and physical properties of POH; the results demonstrate its application as a therapeutic agent.

References
1.
Hashimoto J . Central hemodynamics and target organ damage in hypertension. Tohoku J Exp Med. 2014; 233(1):1-8. DOI: 10.1620/tjem.233.1. View

2.
Fu W, Wang P, Wu H, Zhang Z, Zeng H, Zhang Y . Antihypertensive effects of Trichiurus lepturus myosin hydrolysate in spontaneously hypertensive rats. Food Funct. 2020; 11(4):3645-3656. DOI: 10.1039/c9fo02687h. View

3.
Katz J, Gore J, Amin A, Anderson F, Dasta J, Ferguson J . Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J. 2009; 158(4):599-606.e1. DOI: 10.1016/j.ahj.2009.07.020. View

4.
Ferreira A, Shenoy V, Yamazato Y, Sriramula S, Francis J, Yuan L . Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med. 2009; 179(11):1048-54. PMC: 2689912. DOI: 10.1164/rccm.200811-1678OC. View

5.
Malayeri A, Natori S, Bahrami H, Bertoni A, Kronmal R, Lima J . Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol. 2008; 102(4):491-6. PMC: 2586608. DOI: 10.1016/j.amjcard.2008.04.010. View